Dietary Supplement
Beetroot Juice for Interstitial Lung Disease
Recruiting0 awards5 criteria
Vancouver, British Columbia
This trial is testing if drinking beetroot juice with high nitrate levels can help people with a type of lung disease exercise better. The target group is patients with a type of lung disease, who have difficulty breathing and exercising. The nutrients in the beetroot juice help improve blood flow and muscle function, which may make it easier for these patients to exercise. Beetroot juice, rich in nutrients, has been shown to improve exercise performance and muscle efficiency in various populations.
Behavioural Intervention
Communication Intervention for Dementia
Recruiting1 award12 criteria
Seattle, Washington
This trial is testing whether or not the Jumpstart intervention can improve patient-centered outcomes for those with chronic illness. The study will specifically look at Alzheimer's disease and related dementias, but will also include other common chronic illnesses. The trial will assess the efficacy of the intervention by measuring quality of care, intensity of care outcomes, and patient- and family-reported outcomes. There will also be a mixed-methods evaluation of the implementation of the intervention to explore barriers and facilitators to future implementation and dissemination.
Popular Filters
Trials for Idiopathic Pulmonary Fibrosis Patients
Monoclonal Antibodies
Belimumab for Interstitial Lung Disease
Recruiting1 awardPhase 3
Los Angeles, California
This trial will investigate whether adding a medication called belimumab to standard therapy can help stabilize or improve lung function and reduce symptoms in participants with connective tissue disease-associated interstitial lung disease (ILD).
Behavioural Intervention
Physical Activity and Pulmonary Rehabilitation for Interstitial Lung Disease
Recruiting1 award7 criteria
Tampa, Florida
This trial will measure physical activity of IPF/PF-ILD patients to predict disease progression and explore if it affects quality of life, fatigue, and pulmonary function.
Radiopharmaceutical
FAPI PET for Lung Fibrosis
Recruiting1 awardPhase < 1
Los Angeles, California
This trial is looking at how well a new imaging agent called 68-GaFAPi works in people with interstitial lung disease. The study will follow 30 patients and look at where and how much the agent accumulates in normal and diseased lung tissue.
Trials for ILD Patients
Monoclonal Antibodies
Belimumab for Interstitial Lung Disease
Recruiting1 awardPhase 3
Los Angeles, California
This trial will investigate whether adding a medication called belimumab to standard therapy can help stabilize or improve lung function and reduce symptoms in participants with connective tissue disease-associated interstitial lung disease (ILD).
Behavioural Intervention
Physical Activity and Pulmonary Rehabilitation for Interstitial Lung Disease
Recruiting1 award7 criteria
Tampa, Florida
This trial will measure physical activity of IPF/PF-ILD patients to predict disease progression and explore if it affects quality of life, fatigue, and pulmonary function.
Radiopharmaceutical
FAPI PET for Lung Fibrosis
Recruiting1 awardPhase < 1
Los Angeles, California
This trial is looking at how well a new imaging agent called 68-GaFAPi works in people with interstitial lung disease. The study will follow 30 patients and look at where and how much the agent accumulates in normal and diseased lung tissue.
Phase 3 Trials
Monoclonal Antibodies
Belimumab for Interstitial Lung Disease
Recruiting1 awardPhase 3
Los Angeles, California
This trial will investigate whether adding a medication called belimumab to standard therapy can help stabilize or improve lung function and reduce symptoms in participants with connective tissue disease-associated interstitial lung disease (ILD).
BI 1015550 for Interstitial Lung Disease
Recruiting1 awardPhase 3
Winston-Salem, North Carolina
This trial tests if BI 1015550 can help adults with certain progressive lung diseases. Participants take the medicine as tablets, and their lung function is checked over time to see if it improves. The study aims to find out if this new treatment can slow down the worsening of their lung condition.
Tyrosine Kinase Inhibitor
Nintedanib for Interstitial Lung Disease
Recruiting2 awardsPhase 3
Los Angeles, California
This trial tests the medicine nintedanib in children and teens with lung disease that causes scarring. The goal is to see if long-term use of nintedanib is safe and effective for them. Participants take the medicine and visit the study site for health check-ups. Nintedanib has been shown to slow disease progression and is well tolerated in patients.
Trials With No Placebo
Behavioural Intervention
Physical Activity and Pulmonary Rehabilitation for Interstitial Lung Disease
Recruiting1 award7 criteria
Tampa, Florida
This trial will measure physical activity of IPF/PF-ILD patients to predict disease progression and explore if it affects quality of life, fatigue, and pulmonary function.
Radiopharmaceutical
FAPI PET for Lung Fibrosis
Recruiting1 awardPhase < 1
Los Angeles, California
This trial is looking at how well a new imaging agent called 68-GaFAPi works in people with interstitial lung disease. The study will follow 30 patients and look at where and how much the agent accumulates in normal and diseased lung tissue.
Tyrosine Kinase Inhibitor
Nintedanib for Interstitial Lung Disease
Recruiting2 awardsPhase 3
Los Angeles, California
This trial tests the medicine nintedanib in children and teens with lung disease that causes scarring. The goal is to see if long-term use of nintedanib is safe and effective for them. Participants take the medicine and visit the study site for health check-ups. Nintedanib has been shown to slow disease progression and is well tolerated in patients.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.